• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SS Innovations International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8/7/25 8:50:25 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care
    Get the next $SSII alert in real time by email
    false 0001676163 0001676163 2025-08-07 2025-08-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

     

    Date of report (Date of earliest event reported): August 7, 2025

     

    SS INNOVATIONS INTERNATIONAL, INC.

    (Exact name of registrant as specified in its charter)

     

    Florida   001-42615   47-3478854
    (State or Other Jurisdiction
    of Incorporation)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    405, 3rd Floor, iLabs Info Technology Centre

    Udyog Vihar, Phase III

    Gurugram, Haryana India

      122016
    (Address of Principal Executive Offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: +91 73375 53469

     

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each Class   Trading Symbol   Name of each exchange on which registered
    Common Stock   SSII   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    As used in this Current Report on Form 8-K (this “Current Report”), the terms “SSi,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. and its subsidiaries.

     

    Item 2.02 Results of Operations and Financial Condition.

     

    The disclosure set forth in Item 7.01 of this Current Report is incorporated herein by reference.

     

    Item 7.01 Regulation FD Disclosure.

     

    On August 7, 2025, the Company issued a press release discussing results of operations for the three and six month periods ended June 30, 2025. A copy of the press release is included as Exhibit 99.1 to this Current Report.

     

    The information set forth in Items 2.02 and 7.01 of this Current Report, and in the press release included as Exhibit 99.1 to this Current Report, are deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information set forth in Items 2.02 and 7.01 of this Current Report, and in the press release included as Exhibit 99.1 to this Current Report, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

     

    Forward-Looking Statements:

     

    This Current Report may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SSi’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and uncertainties, although not all risks and uncertainties, that could cause the Company’s actual results to differ materially from those presented in its forward-looking statements are set forth in the Company’s Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission, as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent reports. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to SSi’s operations, results of operations, growth strategy and liquidity.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    Exhibit No.   Description
    99.1   Press Release, dated August 7, 2025
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: August 7, 2025 SS INNOVATIONS INTERNATIONAL, INC.
         
      By:  /s/ Sudhir Srivastava
        Sudhir Srivastava, M.D.
        Chairman and Chief Executive Officer

     

     

    2

     

     

    Get the next $SSII alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SSII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SSII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer

    FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Naveen Kumar Amar as the Company's Chief Financial Officer, effective September 24, 2025. Mr. Amar is assuming the Chief Financial Officer role, on a permanent basis, from Dr. Vishwa Srivastava, who has served as the Company's Interim Chief Financial Officer since July 2025. Dr. Vishwa Srivastava will continue in his capacity as the Company's Chief Executive Officer – Asia

    9/26/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Announces Successful Completion of World's First Pediatric Pyeloplasty Telesurgery Utilizing the Company's SSi Mantra Surgical Robotic System

    FORT LAUDERDALE, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) --  SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the world's first pediatric pyeloplasty telesurgery has been successfully performed utilizing the Company's SSi Mantra surgical robotic system. Dr. Chandra Mohan Vaddi, Managing Director of Preeti Urology & Kidney Hospitals ("Preeti Hospital"), completed the robotic procedure remotely from SS Innovations' headquarters in Gurugram, India, nearly 1,000 miles away from a 16-month-old patien

    9/16/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Announces Successful Completion of First Robotic Telesurgery Performed from the Company's MantraM Mobile Robotic Telesurgery Unit

    FORT LAUDERDALE, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the first robotic telesurgery performed from the Company's MantraM mobile robotic telesurgery unit (the "MantraM bus"). Dr. Priya Bhave Chittawar, Founder and Managing Director of Harmony Institute of Excellence in Reproductive Health ("HER Health"), guided a complex hysterectomy remotely from the MantraM bus utilizing the Company's SSi Mantra surgical robotic syst

    9/9/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    SEC Filings

    View All

    SS Innovations International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - SS Innovations International, Inc. (0001676163) (Filer)

    9/26/25 8:30:36 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - SS Innovations International, Inc. (0001676163) (Filer)

    9/16/25 8:30:27 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - SS Innovations International, Inc. (0001676163) (Filer)

    9/9/25 8:30:29 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: COO - Americas Cohen Barry F bought $3,799 worth of shares (426 units at $8.92), increasing direct ownership by 0.00% to 8,866,888 units (SEC Form 4)

    4/A - SS Innovations International, Inc. (0001676163) (Issuer)

    6/30/25 6:55:24 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Srivastava Sudhir received a gift of 2,500 shares and gifted 105,000 shares (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    9/8/25 4:30:12 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    Chairman and CEO Srivastava Sudhir gifted 111,000 shares and received a gift of 60,000 shares (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    8/13/25 5:53:10 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    COO - Americas Cohen Barry F gifted 1,000,000 shares, decreasing direct ownership by 11% to 7,866,888 units (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    6/30/25 7:06:03 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Leadership Updates

    Live Leadership Updates

    View All

    SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer

    FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Naveen Kumar Amar as the Company's Chief Financial Officer, effective September 24, 2025. Mr. Amar is assuming the Chief Financial Officer role, on a permanent basis, from Dr. Vishwa Srivastava, who has served as the Company's Interim Chief Financial Officer since July 2025. Dr. Vishwa Srivastava will continue in his capacity as the Company's Chief Executive Officer – Asia

    9/26/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Announces Chief Financial Officer Transition

    FORT LAUDERDALE, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Arvind Palaniappan as the Company's Interim Chief Financial Officer, effective May 1, 2025, pursuant to a planned leadership transition. Anup Sethi, SS Innovations' departing CFO, will remain available to advise the Company prior to the appointment of a permanent CFO.   SS Innovations has commenced a search process to identify and recruit a permanent successor for the CFO role

    5/2/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care